But you’d be mistaken if you thought radical socialist ideas were somehow a new feature of the Democratic Party. Last month, Senate Finance Committee Democrats, led by Ron Wyden (D-OR), dropped a new drug pricing blueprint that makes their real goal hard to miss. In short, it's a clear signal of Democrats’ next step in their long march to capture the U.S. healthcare system, including the pharmaceutical industry. The Senate Finance Democrats’ “commonsense” drug pricing RFI is anything but modest. President Trump has demonstrated you don’t need a thousand-page statute or government dictate to achieve lower drug prices.